Kano Therapeutics harnesses the power of DNA nanotechnology and synthetic biology to design and engineer novel gene vectors. Our goal is to expand the reach of genome-editing-based therapies through the development of transformational biomaterials. Instead of innovating around the messenger (gene delivery systems, gene editing tools), we start by innovating around the message - the DNA vector that carries the genetic information.



Join TechBio Companies Driving Patient Impact